Publications by authors named "Agata Rusinek"
Article Synopsis
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is influenced by genetic and environmental factors, leading to issues like altered fat metabolism and lipotoxicity, alongside complications such as inflammation and insulin resistance.
- Resveratrol, a natural compound, shows promise in combating MASLD by exhibiting anti-inflammatory and antioxidant properties, and it works by modulating certain biological pathways and improving gut health.
- Despite positive results in lab and animal studies, human clinical trials on resveratrol for MASLD have been inconsistent, potentially due to differences in study designs, low absorption rates of resveratrol, and varying responses among individuals.
